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Application of Head-up Tilt Table Testing in Children
Wei-Ting Lai,1 Ming-Ren Chen,1,2 Shan-Miao Lin,1 Haw-Kwei Hwang1,2,3*
Background/Purpose: We investigated the application of head-up tilt table testing (HUT) and manage-
ment of neurocardiogenic syncope (NCS) in children, as pediatric studies are limited.
Methods: Seventy-nine patients (ages 6–18 years) underwent HUT for evaluation of syncope. Patient trig-
gers and premonitory symptoms allowed the clinical diagnosis of NCS or non-NCS. Results were divided
into four hemodynamic types (1, 2A, 2B, and 3) according to patient response to HUT.
Results: NCS occurred in 65 patients and non-NCS in 14 patients. Isoproterenol infusion significantly in-
creased the sensitivity of the test (from 28% to 45%) and was associated with a slight decrease in the speci-
ficity (from 93% to 86%). Subjects in the type 1 group accounted for the majority of responses to the test
(69%). There were no complications associated with the test. At follow-up (16.6 ± 9.3 months), the over-
all recurrence rate was 30.8% but NCS was less severe in most patients. The recurrence rate was similar for
patients with a positive or negative HUT and for both pharmacologically and non-pharmacologically
treated patients.
Conclusion: HUT can be safely performed with a high specificity in children, with the sensitivity of HUT
improved by isoproterenol. Therefore, a positive response to treatment is reassuring to the physician and
family. NCS is generally a self-limited condition despite a high recurrence rate.
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Syncope is often a frustrating clinical problem in
pediatric patients. Defined as a sudden and tran-
sient loss of consciousness and postural tone with
spontaneous recovery, it appears to be common,
with as many as 15% of children having at least
one syncopal event before the end of adolescence.1
It is often benign, but may rarely reflect signifi-
cant cardiac, neurological, or metabolic pathology.
Presyncope is defined as any of the various pre-
monitory signs of an imminent syncope.2
Head-up tilt table testing (HUT) has gained
considerable value in the diagnostic evaluation
of syncope.3 However, previous studies have re-
ported a low sensitivity rate of HUT.2 Neuro-
cardiogenic syncope (NCS) is the most likely
cause of pediatric syncope.1,3 Due to a limited
number of pediatric studies, we investigated the
application of HUT in children, focusing on its
sensitivity, specificity, and patient hemodynamic
response to the test.
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Materials and Methods
Between November 2005 and September 2008, 79
patients under the age of 18 years who underwent
HUT for evaluation of syncope or presyncope were
enrolled in the study. The 37 boys and 42 girls had
a mean age of 12.4 ± 3.2 years (range, 5.5–18.0
years). Patients with abnormal heart structure were
excluded from the study.
The study cohort was divided into two groups
based on clinical diagnosis. Patients who demon-
strated triggers or premonitory symptoms typical
of NCS were clinically diagnosed as having NCS.
Typical NCS triggers included prolonged motion-
less standing, especially in warm weather or a
crowded environment, standing up quickly or aris-
ing from squatting, emotional stimuli and pain
(venipuncture, immunization, sight of blood),
fasting, lack of sleep, fatigue, menstruation, illness
with fever, micturition, hyperventilation and strain-
ing (self-induced), stretching, coughing, rapid
weight loss, and certain medications such as al-
cohol and illicit drugs. Typical premonitory symp-
toms of NCS included lightheadedness, dizziness,
palpitations, weakness, dimming or blurred vi-
sion, nausea, epigastric distress, feeling warm or
cold, facial pallor, and sweating. Patients without
the aforementioned triggers or premonitory symp-
toms were clinically diagnosed as not having NCS.
After obtaining written informed consent, pa-
tients underwent HUT the morning following an
overnight fast. Resuscitation equipment was at
hand and ready in the catheterization room.
Patients remained supine for 10 minutes while
baseline electrocardiograph and blood pressure re-
cordings were established using peripheral intra-
venous lines. Patients were then tilted to a head-up
position with a calibrated angle of 80° for 30
minutes (stage 1). Heart rhythm was monitored
continuously, and blood pressure was recorded
every 3 minutes (shortened if symptoms appeared)
using an automatic sphygmomanometer. If the
patient developed lightheadedness or syncope at
any time in the first stage associated with hypoten-
sion or bradycardia (positive result), the patient
was immediately returned to the supine position
and given intravenous fluid if needed. The test
was then stopped. If the patient had no symp-
toms in the first stage, isoproterenol infusion
titrated within a range of 0.5–1 μg/min was ad-
ministered (stage 2), targeting a 25% increase of
basic heart rate. The test was finished if isopro-
terenol infusion did not produce hypotension or
bradycardia within 30 minutes (negative result).
Subjects giving a positive result were further di-
vided into four hemodynamic types (1, 2A, 2B, and
3) according to a new classification system pro-
posed by the European Task Force on Syncope
(Table 1).4 Positive results in NCS group and
non-NCS group patients were considered true
positive and false positive, respectively. Recurrence
was defined as reappearance of frank syncope or
its premonitory symptoms at follow-up.
Data are presented as means ± standard devia-
tion for continuous variables and as frequencies for
categorical variables. Differences were assessed
using t test for continuous variables and Fisher’s
exact test for categorical variables. A value of 
p < 0.05 was considered statistically significant.
Results
The demographic and characteristic data of the
study cohort are shown in Table 2. There were 
65 patients in NCS group (syncope: 47, presyn-
cope: 18) and 14 in non-NCS group (syncope: 6,
presyncope: 8). There was no significant difference
between the two groups in age (p = 0.45), gender
Table 1. Classification of hemodynamic types according
to the European Task Force on Syncope
Type Definition
1 Mixed type. Heart rate falls at the time of 
syncope but does not fall to < 40 bpm. Blood 
pressure falls before heart rate falls.
2A Cardioinhibition without asystole. Heart 
rate falls to < 40 bpm for > 10 sec.
2B Cardioinhibition with asystole. Asystole 
occurs for > 3 sec.
3 Vasodepressor. Heart rate does not fall > 10% 
from its peak at the time of syncope.
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(p = 0.79), or the frequency of morning episodes
(15.4% vs. 25.0%, p = 0.618). Of the non-NCS
patients, six had frank syncope. Two patients had
cardiac arrhythmias. One with correlating sec-
ond degree atrioventricular block accepted per-
manent pacemaker implantation. The other with
frequent premature ventricular contraction was
treated with daily oral atenolol 25 mg with good
symptom control. Neurological causes were iden-
tified in two patients with abnormal electro-
encephalogram. No definite cause was identified
in the remaining two syncopal patients. There
was no significant difference in the hemoglobin
(13.8 ± 1.3 g/dL vs. 13.6 ± 1.4 g/dL, p = 0.76) or
mean corpuscular volume (86.4 ± 5.7 fL vs. 86.7 ±
3.9 fL, p = 0.90) between the two groups.
The number from the entire cohort having a
positive or negative response to complete HUT
(with stage 2 if needed), or if only stage 1 was per-
formed, is shown in Table 3. Isoproterenol infusion
significantly increased the sensitivity of the test
(from 28% to 45%, p = 0.045) associated with a
slight decrease in the specificity (from 93% to
86%, p = 1.000).
Table 4 shows the hemodynamic types in re-
sponse to HUT in group 1 patients. Type 1 ac-
counted for the majority of responses to the test
(20/29, 69%). Type 2 accounted for 28% (8/29)
Table 2. Demographic and characteristic data from patients undergoing head-up tilt table testing*
NCS group (n = 65) non-NCS group (n = 14) Total (n = 79)
Age (yr) 12.3 ± 3.0 13.0 ± 4.0 12.4 ± 3.2
Sex, male:female 30:35 7:7 37:42
Number of syncope 47 6 53
Cardiac cause 0 1 PVC, 1 second-degree AVB 2
Neurological cause 0 2 abnormal EEG 2
Morning episodes (%) 15.4 25.0 19.0
Hemoglobin (g/dL) 13.8 ± 1.3 13.6 ± 1.4 13.8 ± 1.3 
Mean CV (fL) 86.4 ± 5.7 86.7 ± 3.9 86.5 ± 5.4
*Data presented as n, n (%) or mean ± standard deviation. NCS = neurocardiogenic syncope; PVC = premature ventricular contraction;
AVB = atrioventricular block; EEG = electroencephalogram; CV = corpuscular volume.
Table 3. Number of the entire cohort who had a positive or negative response to the complete head-up tilt
table testing (stages 1 + 2) or if only stage 1 was performed
Positive Negative
Only stage 1 Stages 1 + 2 Only stage 1 Stages 1 + 2
Group 1 (n = 65) 18 29 47 36
Group 2 (n = 14) 1 2 13 12
Total patients (n = 79) 19 31 60 48
Table 4. Number of the hemodynamic types in response to the complete head-up tilt table testing in the
group 1 patients with syncope or pre-syncope
Types Type 1 Type 2A Type 2B Type 3 Negative
Syncope (n = 47) 12 4 3 1 27
Pre-syncope (n = 18) 8 1 0 0 9
Total patients (n = 65) 20 5 3 1 36
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and type 3 only 3% (1/29). Three patients had
asystole (Type 2B) during the test (Figure), and
recovered after lying down and bed rest. There
were no complications associated with the test.
All patients were treated and followed up in
the clinic. In NCS group, most patients accepted
non-pharmacologic treatment (education and in-
creasing fluid and salt intake). Only 10 (15.4%)
accepted short-term pharmacologic treatment 
(β blocker: 9, diphenidol: 1).
At follow-up (16.6 ± 9.3 months), the overall
recurrence rate in NCS group was 30.8% but most
patients’ experiences were less severe and they had
only premonitory symptoms. The recurrence rate
was similar for NCS patients regardless of a posi-
tive or negative HUT and pharmacologic or non-
pharmacologic treatment.
Discussion
The incidence of syncope requiring medical atten-
tion in children is 0.05–0.3%, with its peak around
15 years of age. Females are twice as likely to ex-
perience syncope as males.1 The most common
cause of syncope in children is NCS, particularly a
vasovagal faint. Differential diagnoses include
potentially dangerous disorders such as arrhyth-
mia or ventricular outflow tract obstruction, which
are far less common in children than adults.1
The most important part of diagnostic evalua-
tion is obtaining a good history and performing a
complete physical examination. Laboratory testing
is usually costly and has a low diagnostic yield.5
A 12-lead electrocardiograph should be used as a
screening tool for unusual cardiac causes. If there is
doubt about the diagnosis, cardiac causes must be
ruled out and eventually a HUT can be performed.
The benefits of HUT include reassurance for the
physician and family of a patient with recurrent
syncope, reducing anxiety for the patient, as well
as providing a useful teaching therapy.
The safety of HUT in children is probably of
the greatest concern. The majority of adverse events
of HUT for patients with normal heart structure
are reportedly related to isoproterenol challenge.3,6
Some of our patients experienced palpitations and
chest pain with isoproterenol infusion, but the dis-
comfort gradually subsided after the test. Al-
though three of our patients experienced asystole
during the test, they completely recovered after
lying down. Therefore, we demonstrated that
HUT can be safely performed in children.
A drawback for HUT is a high false-negative
rate (up to 50% in adults). However, the accu-
racy of HUT can be improved with isoproterenol
infusion. In our study, isoproterenol infusion
significantly increased the sensitivity of the test
(from 28% to 45%) and was associated with a
slight decrease in specificity (from 93% to 86%).
In other protocols, isoproterenol 0.05 μg/kg/min
(to a maximum of 5μg/min) was administered for
5 minutes in a supine position, then 10 minutes in
tilt, and discontinued if adverse effects occured.7,8
We may have observed a higher false-positive
rate due to a longer duration of isoproterenol 
infusion, which was up to 30 minutes in our 
protocol.
Figure. A 10-year-old boy experienced sinus bradycardia and atrioventricular block with progression to asystole lasting
for 9 seconds at 20 minutes of the stage 1 tilt table testing.
Tilt table testing in children
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We, and other investigators, have reported
mixed type NCS to be the most common response
to HUT, whereas others reported mainly the
vasodepressor variety in young patients.9 This dif-
ference could be related to the timing of returning
the patient to the supine position when symptoms
occurred. The earlier the patient was returned to
a lying position, the less significantly the heart
rate fell.
The mainstay of management of NCS includes
education surrounding the factors that influence
blood pressure and intravascular volume expan-
sion. Many medications used in the treatment of
syncope, such as fludrocortisone and metoprolol,
have been reported to have a significant placebo
effect.10,11 Also, undesirable side effects often out-
weigh any positive effects. In our study, most 
patient experiences were less severe at follow-up
with non-pharmacologic treatment alone. We also
obtained a similar recurrence rate of NCS for
pharmacologically and non-pharmacologically
treated patients, and also for patients with either
a positive or a negative tilt test. Therefore, we sug-
gest that pharmacologic treatment be reserved for
the rare patient with continued symptoms after
non-pharmacologic treatment approaches have
been used.
Episodes of syncope have been reported to be
concentrated in the morning in HUT positive pa-
tients, therefore diurnal variation in autonomic
function may be a factor contributing to this ob-
servation.12 In our study, the frequency of morn-
ing episodes of NCS patients was not significantly
different from that of non-NCS patients. Low
iron storage has also been reported to be associ-
ated with NCS, indicating a potential pathophys-
iological factor related to NCS.13 Iron storage
was not investigated in the present study. Never-
theless, we did not find any difference in the he-
moglobin or mean corpuscular volume level
between NCS and non-NCS patients. More data
is needed to explain these discrepancies.
This study is limited in several ways. First, to
analyze the sensitivity and specificity of HUT, the
diagnosis of NCS was made based on the clinical
symptoms. Second, HUT can provide a good
teaching therapy, educating the patient to avoid
frank syncope during premonitory symptoms,
and thereby theoretically preventing recurrence of
NCS. However, we obtained a similar recurrence
rate of NCS for patients with either a positive 
or a negative HUT. In an earlier study by Morillo
et al,14 a reduction in syncope was observed in
patients who underwent repeated tilt tests. We
did not perform tilt training in this study. A single
HUT may be insufficient to reduce recurrence 
of NCS.
In conclusion, neurocardiogenic syncope is
generally a self-limited condition. HUT has a
high specificity; therefore, a positive response is
reassuring for both the physician and family.
Isoproterenol infusion can safely improve the
sensitivity of the test in children.
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